Genmab A (GMAB) Operating Income Growth (1y) (2019 - 2026)
Genmab A (GMAB) Operating Income Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 100.00% |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 12.69% |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 75.16% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -347.04% |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 1.27% |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 80.62% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | -4.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.26% |
| Sep 30, 2025 | 48.06% |
| Jun 30, 2025 | 52.54% |
| Mar 31, 2025 | 62.07% |
| Sep 30, 2020 | 244,630,530,916,680,204,288.00% |
| Dec 31, 2019 | -100.00% |